Strategic Initiative

Slingshot members are tracking this corporate initiative:

Otsuka (OTSKY) and Akebia (AKBA) Announce U.S Collaboration and License Agreement for Vadadustat in Treatment of Anemia in Patients with Chronic Kidney Disease

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AKBA

100%
OTSKY

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Dec 13, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Collaboration, License Agreement, Vadadustat, Anemia, Chronic Kidney Disease